DrBulletin

Research news updated daily

Interventional neuroradiology

23 October 2026

In our update for Friday 23 October 2026, studies on automated carotid artery atherosclerotic inflammation segmentation in PET and enhancements in reference internal dosimetry data for the MOBY whole-body computational phantom of the laboratory mouse were highlighted.

Carotid stenosis

Automated carotid artery atherosclerotic inflammation segmentation in PET using MSR-Net.

Li et al. (Physics in Medicine and Biology) developed an automated method for segmenting and quantifying carotid atherosclerotic inflammation on PET images. They used a two-stage network with a multiscale residual convolutional backbone to localize the vessel wall and estimate inflammation fraction. The proposed method outperformed other deep learning baselines in terms of Dice similarity coefficient and Hausdorff distance. Interestingly, corrected SUV showed a positive association with MR-derived lipid-rich/necrotic core with hemorrhage in seven patients. While the results are promising, external validation with biological reference standards is needed before clinical use. This study highlights the potential for improved carotid PET segmentation and uptake quantification.

Original research

Enhancements and reference internal dosimetry data for the MOBY whole-body computational phantom of the laboratory mouse.

Carrasco-Rojas et al. (2021) presented enhancements to the MOBY whole-body computational phantom for laboratory mice in Physics in Medicine and Biology. The study refined skeletal structures, added sex-specific anatomical details, and improved organ-level dose assessments. Using Blender software, tetrahedral mesh-based phantoms were developed, with Monte Carlo simulations performed to compute SAFs and S-values for different radionuclides. The study provides a robust dataset for preclinical radiation dosimetry, supporting dose-response radiopharmaceutical research. The incorporation of sex-specific anatomical details and an improved skeletal model in the refined MOBY phantoms represents a significant advancement in preclinical dosimetry, with potential implications for human dose estimation frameworks.

Upcoming events

We hope you enjoyed this edition of our newsletter! Have a great day!

22 October 2026

In our update for Thursday 22 October 2026, two studies on acute ischemic stroke were examined, focusing on the impact of RapidAI® implementation on stroke care outcomes and the agreement between PMAneo and RAPID in CT perfusion analysis.

Stroke

Impact of RapidAI® Implementation on Workflow Metrics and Access to Reperfusion Therapies in Acute Ischemic Stroke: A 10-Year Retrospective Analysis.

In a retrospective cohort study by González et al. in Cerebrovasc Dis, the impact of RapidAI® implementation on workflow metrics and access to reperfusion therapies in acute ischemic stroke was evaluated. The study found no significant differences in the utilization of intravenous thrombolysis or mechanical thrombectomy between pre- and post-implementation periods. However, there was a decrease in rescue decompressive craniectomy and hospital length of stay post-implementation. Interestingly, door-to-needle time and functional outcomes showed no significant differences. The authors caution that findings should be interpreted cautiously due to low software utilization and potential secular trends. This study highlights the importance of evaluating the impact of new technologies on stroke care outcomes.

Stroke

Comparison of PMAneo and RAPID in acute ischemic stroke: agreement in CT perfusion analysis and DEFUSE 3 imaging eligibility.

In a retrospective cohort study by Ikebe et al. in J J Radiol, the agreement between PMAneo and RAPID in CT perfusion analysis for acute ischemic stroke was evaluated. The study included 99 patients from three stroke centers using four CT scanners. PMAneo showed high agreement with RAPID in ischemic core volumes and DEFUSE 3 imaging eligibility criteria. However, there was proportional bias with PMAneo underestimating volumes as lesion size increased. Basal ganglia involvement and imaging site were associated with volume differences. Despite some discrepancies in borderline cases, PMAneo may offer a reliable alternative for automated CTP analysis, potentially expanding access to this technology.

Upcoming events

Thanks for taking the time to read our newsletter! Have a great day!

21 October 2026

In our update for Wednesday 21 October 2026, studies on neuromodulation using low-intensity focused ultrasound and arteriovenous malformation management in pediatric patients were highlighted.

Original research

Low-intensity focused ultrasound for neuromodulation: neuroimaging and neurointerventional perspectives.

Coetzee et al. (AJNR) reviewed the use of low-intensity focused ultrasound (LIFU) for neuromodulation, highlighting its noninvasive nature and ability to modulate neuronal activity without tissue ablation. The authors discussed the technical background, clinical applications, and safety of LIFU from neuroimaging and neurointerventional perspectives. They emphasized the growing evidence base and diverse applications of LIFU in targeting specific brain structures. This review provides valuable insights into the potential of LIFU as a neuromodulation technique, with implications for future research and clinical practice.

Arteriovenous malformation

An enlarged nonfistulous artery mimicking an additional feeder in a pediatric pial arteriovenous fistula: an angiographic pitfall.

In a recent case report by Aksoy et al. in Neuroradiology, a pediatric patient with a pial arteriovenous fistula (PAVF) presented with an enlarged nonfistulous artery adjacent to the lesion, initially raising concerns of additional feeder vessels. However, superselective angiography revealed normal arterial arborization and perfusion, ruling out direct participation in the arteriovenous shunt. Selective coil embolization successfully occluded the fistulous communication while preserving normal cortical arterial supply. This case emphasizes the importance of careful angiographic evaluation in distinguishing true feeder vessels in PAVFs, preventing unnecessary treatment of nonfistulous arteries. This study serves as a valuable reminder of potential angiographic pitfalls in the management of complex vascular lesions.

Upcoming events

We hope you enjoyed this edition of our newsletter! Have a great day!